BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kiri VA, Pride NB, Soriano JB, Vestbo J. Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: Results from Two Observational Designs Free of Immortal Time Bias. Am J Respir Crit Care Med 2005;172:460-4. [DOI: 10.1164/rccm.200502-210oc] [Cited by in Crossref: 57] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Karim ME, Gustafson P, Petkau J, Tremlett H; Long-Term Benefits and Adverse Effects of Beta-Interferon for Multiple Sclerosis (BeAMS) Study Group. Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies. Am J Epidemiol 2016;184:325-35. [PMID: 27455963 DOI: 10.1093/aje/kwv445] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 7.8] [Reference Citation Analysis]
2 Zhang ZJ. Metformin and Reduced Risk of Cancer in the Hong Kong Diabetes Registry: Real Effect or Immortal Time Bias? J Gen Intern Med 2019;34:1154-7. [PMID: 31025306 DOI: 10.1007/s11606-019-04982-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
3 Suissa S. Randomized Trials Built on Sand: Examples from COPD, Hormone Therapy, and Cancer. Rambam Maimonides Med J 2012;3:e0014. [PMID: 23908838 DOI: 10.5041/RMMJ.10082] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
4 Cazzola M, Hanania NA. The role of combination therapy with corticosteroids and long-acting beta2-agonists in the prevention of exacerbations in COPD. Int J Chron Obstruct Pulmon Dis 2006;1:345-54. [PMID: 18044091 DOI: 10.2147/copd.2006.1.4.345] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
5 Mannino DM, Kiriz VA. Changing the burden of COPD mortality. Int J Chron Obstruct Pulmon Dis 2006;1:219-33. [PMID: 18046859 DOI: 10.2147/copd.2006.1.3.219] [Cited by in Crossref: 7] [Cited by in F6Publishing: 30] [Article Influence: 0.5] [Reference Citation Analysis]
6 Giembycz MA, Kaur M, Leigh R, Newton R. A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids. Br J Pharmacol 2008;153:1090-104. [PMID: 18071293 DOI: 10.1038/sj.bjp.0707627] [Cited by in Crossref: 95] [Cited by in F6Publishing: 88] [Article Influence: 6.8] [Reference Citation Analysis]
7 Kiri VA. A pathway to improved prospective observational post-authorization safety studies. Drug Saf 2012;35:711-24. [PMID: 22861669 DOI: 10.1007/BF03261968] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
8 Mumford SL, Schisterman EF, Cole SR, Westreich D, Platt RW. Time at risk and intention-to-treat analyses: parallels and implications for inference. Epidemiology 2015;26:112-8. [PMID: 25275571 DOI: 10.1097/EDE.0000000000000188] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Adil MS, Khan MA, Khan MN, Sultan I, Khan MA, Ali SA, Farooqui A. EMPADE Study: Evaluation of Medical Prescriptions and Adverse Drug Events in COPD Patients Admitted to Intensive Care Unit. J Clin Diagn Res 2015;9:FC05-8. [PMID: 26675667 DOI: 10.7860/JCDR/2015/14563.6721] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
10 Falk JA, Minai OA, Mosenifar Z. Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5:506-12. [PMID: 18453363 DOI: 10.1513/pats.200707-096ET] [Cited by in Crossref: 42] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]